JOURNAL OF RADIOLOGICAL PROTECTION, cilt.36, sa.2, ss.269-278, 2016 (SCI-Expanded, Scopus)
The aim of this study is to investigate the outpatient treatment protocol and radiation safety of a new-emerging lutetium-177 (Lu-177) prostate specific membrane antigen (PSMA) therapy.